Advertisement

Der Anaesthesist

, Volume 69, Issue 1, pp 52–54 | Cite as

Additive Therapien

Intensivmedizinische Studien aus 2018/2019
  • M. Dietrich
  • C. J. Reuß
  • C. Beynon
  • A. Hecker
  • C. Jungk
  • D. Michalski
  • C. Nusshag
  • K. Schmidt
  • M. A. Weigand
  • M. Bernhard
  • T. BrennerEmail author
Journal Club
  • 614 Downloads

Infobox

Dieser Beitrag ist Teil einer Serie zu den wichtigsten Intensivmedizinische Studien aus 2018/2019. Weitere Teile der Serie sind:
  • Editorial: Coburn M (2019) Intensivmedizinische Studien aus 2018/2019. Anaesthesist.  https://doi.org/10.1007/s00101-019-00638-z

  • Flüssigkeitstherapie: Reuß CJ, Dietrich M, Beynon C et al (2019) Flüssigkeitstherapie. Intensivmedizinische Studien aus 2018/2019. Anaesthesist.  https://doi.org/10.1007/s00101-019-00639-y

  • Beatmung und Sauerstofftherapie: Dietrich M, Reuß CJ, Beynon C et al (2019) Beatmung und Sauerstofftherapie. Intensivmedizinische Studien aus 2018/2019. Anaesthesist.  https://doi.org/10.1007/s00101-019-00640-5

  • Fokus Nephrologie: Nusshag C, Beynon C, Dietrich M et al (2019) Fokus Nephrologie. Intensivmedizinische Studien aus 2018/2019. Anaesthesist.  https://doi.org/10.1007/s00101-019-00641-4

  • Neurologische Intensivmedizin: Michalski D, Jungk C, Brenner T et al (2019) Neurologische Intensivmedizin. Intensivmedizinische Studien aus...

Additive therapies

Intensive care studies from 2018–2019

Notes

Interessenkonflikt

M. Dietrich, C.J. Reuß, C. Beynon, A. Hecker, C. Jungk, D. Michalski, C. Nusshag, K. Schmidt, M.A. Weigand, M. Bernhard und T. Brenner geben an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Devlin JW et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 46(9):e825–e873CrossRefGoogle Scholar
  2. 2.
    Girard TD et al (2018) Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study. Lancet Respir Med 6(3):213–222CrossRefGoogle Scholar
  3. 3.
    Pisani MA et al (2009) Days of delirium are associated with 1‑year mortality in an older intensive care unit population. Am J Respir Crit Care Med 180(11):1092–1097CrossRefGoogle Scholar
  4. 4.
    Shehabi Y et al (2010) Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med 38(12):2311–2318CrossRefGoogle Scholar
  5. 5.
    Ely EW et al (2001) The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 27(12):1892–1900CrossRefGoogle Scholar
  6. 6.
    Girard TD et al (2018) Haloperidol and Ziprasidone for treatment of delirium in critical illness. N Engl J Med 379(26):2506–2516CrossRefGoogle Scholar
  7. 7.
    Ely EW et al (2001) Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 29(7):1370–1379.CrossRefGoogle Scholar
  8. 8.
    Girard TD et al (2008) Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomised controlled trial. Lancet 371(9607):126–134CrossRefGoogle Scholar
  9. 9.
    Ely EW, Bundle TABCDEF (2017) Science and philosophy of how ICU liberation serves patients and families. Crit Care Med 45(2):321–330CrossRefGoogle Scholar
  10. 10.
    Balas MC et al (2013) Implementing the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle into everyday care: opportunities, challenges, and lessons learned for implementing the ICU pain, agitation, and delirium guidelines. Crit Care Med 41(9 Suppl 1):S116–27CrossRefGoogle Scholar
  11. 11.
    Krag M et al (2018) Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N Engl J Med 379(23):2199–2208CrossRefGoogle Scholar
  12. 12.
    Krag M et al (2015) Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 41(5):833–845CrossRefGoogle Scholar
  13. 13.
    Kumar S et al (2017) Incidence and risk factors for gastrointestinal bleeding among patients admitted to medical intensive care units. Frontline Gastroenterol 8(3):167–173CrossRefGoogle Scholar
  14. 14.
    Barletta JF, Sclar DA (2014) Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Crit Care 18(6):714CrossRefGoogle Scholar
  15. 15.
    MacLaren R, Reynolds PM, Allen RR (2014) Histamine‑2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. Jama Intern Med 174(4):564–574CrossRefGoogle Scholar
  16. 16.
    Ro Y et al (2016) Risk of Clostridium difficile infection with the use of a proton pump inhibitor for stress ulcer prophylaxis in critically ill patients. Gut Liver 10(4):581–586CrossRefGoogle Scholar
  17. 17.
    Attia J et al (2001) Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161(10):1268–1279CrossRefGoogle Scholar
  18. 18.
    Alhazzani W et al (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41(9):2088–2098CrossRefGoogle Scholar
  19. 19.
    Cook DJ, Crowther MA (2010) Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients. Crit Care Med 38(2 Suppl):76–82CrossRefGoogle Scholar
  20. 20.
    Arabi YM et al (2013) Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity scores adjusted analysis. Chest 144(1):152–159CrossRefGoogle Scholar
  21. 21.
    Ibrahim EH et al (2002) Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med 30(4):771–774CrossRefGoogle Scholar
  22. 22.
    Kaplan D et al (2015) VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest 148(5):1224–1230CrossRefGoogle Scholar
  23. 23.
    Qaseem A et al (2011) Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 155(9):625–632CrossRefGoogle Scholar
  24. 24.
    Kahn SR et al (2012) Prevention of VTE in nonsurgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e195S–e226SCrossRefGoogle Scholar
  25. 25.
    Arabi YM et al (2019) Adjunctive intermittent pneumatic compression for venous Thromboprophylaxis. N Engl J Med 380(14):1305–1315CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • M. Dietrich
    • 1
  • C. J. Reuß
    • 1
  • C. Beynon
    • 2
  • A. Hecker
    • 3
  • C. Jungk
    • 2
  • D. Michalski
    • 4
  • C. Nusshag
    • 5
  • K. Schmidt
    • 1
  • M. A. Weigand
    • 1
  • M. Bernhard
    • 6
  • T. Brenner
    • 1
    Email author
  1. 1.Klinik für AnästhesiologieUniversitätsklinikum HeidelbergHeidelbergDeutschland
  2. 2.Neurochirurgische KlinikUniversitätsklinikum HeidelbergHeidelbergDeutschland
  3. 3.Klinik für Allgemein- Viszeral‑, Thorax‑, Transplantations- und KinderchirurgieUniversitätsklinikum Gießen und Marburg, Standort GießenGießenDeutschland
  4. 4.Neurologische Intensivstation und Stroke Unit, Klinik und Poliklinik für NeurologieUniversitätsklinikum Leipzig AöRLeipzigDeutschland
  5. 5.Klinik für Endokrinologie, Stoffwechsel und klinische Chemie/Sektion NephrologieUniversitätsklinikum HeidelbergHeidelbergDeutschland
  6. 6.Zentrale NotaufnahmeUniversitätsklinikum DüsseldorfDüsseldorfDeutschland

Personalised recommendations